The phosphorylation of transcription factor CP2-like 1 (TFCP2L1) by CDK1 at Thr177 promotes bladder carcinogenesis, and the tumorigenic potency of bladder cancer cells was reduced in a xenograft model when the level of TFCP2L1 phosphorylation was decreased [36]. Here, TFCP2L1 is linked to urinary bladder carcinoma.